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Article Synopsis 
This article describes a qualitative research study using focus groups to explore the views and 
experiences of a medicines management team (MMT) on the service they deliver within a ‘Virtual 
Ward’ (VW); and those of the wider multidisciplinary team of healthcare professionals on the service 
provided by MMT.  Several themes emerged from the focus groups, including impact on patients and 
carers, team working and issues and challenges.  A dedicated medicines management team was 
seen as a positive contribution to the VW, which potentially increased the quality of patient care, 
and appeared to be a positive experience for both the MM and wider multidisciplinary teams.   
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Health care professionals’ perceptions of a community based ‘Virtual Ward’ medicines 
management service: a qualitative study. 
Introduction 
Within England, the organisation of the National Health Service (NHS) delivered in the 
community setting falls under the domain of local Clinical Commissioning Groups (CCGs). 
This study is based within an NHS CCG in the North West (NW) of England serving a 
population of around 155,000 residents across four localities; and currently utilises a hospital 
avoidance intervention in the form of a Virtual Ward (VW). Virtual wards first described by 
Lewis,1 can be defined as a model of care that: 
“. . . provides multi-disciplinary case management services to people who have been 
identified, using a predictive model, as high risks for future emergency 
hospitalisation. Virtual wards use the systems, staffing, and daily routine of a hospital 
ward to deliver preventive care to patients in their own homes.” 2 
Variations of Lewis’s model have been adopted nationally and internationally, with evidence 
highlighting that hospital avoidance programmes are most effective when offered to people 
who are at high risk of future hospitalisation, rather than those who are currently 
experiencing multiple hospital admissions.3 As such, the integrated multi-disciplinary 
preventative care provided by VWs may be of most benefit to people with long-term 
conditions and complex health and social care needs; typically older people receiving 
fragmented care by a number of care providers. A report by the Nuffield Trust estimated that 
between 2012/13 and 2021/22, the number of people aged 65 years or over in the United 
Kingdom (UK) will increase by 20%, and those aged over 85 years will increase by 33%. 4  
Further estimates suggest that by 2035, those aged 65+ will account for 23% of the total 
population, and that the number of people aged 85+ will reach 3.5 million (accounting for 5% 
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of the total UK population).5 Across Europe it is projected that by 2035 up to a third of the 
population will be aged 65+, with emerging economies (such as China and India) expecting 
to experience a two fold increase in this age group.6 Moreover, in 2014 there were estimated 
to be more than half a million people aged 90+ living in the UK and over the last 30 years the 
number of centenarians in the UK has quadrupled.7 Similar increases in the numbers of 
centenarians are also seen in other countries, and the current estimate of 317,000 worldwide 
is projected to reach 18 million by the end of the century.8 Therefore, it can be anticipated 
that many of the elderly will have increasing multiple long term conditions that will need 
supporting. 
In his original model, Lewis proposed that the composition of a VW multi-disciplinary team 
(MDT) should vary according to the needs of the local high risk patients; and suggested 
pharmacists as potential  team members.1 Furthermore, the inclusion of pharmacy technicians 
serves to create a medicines management team within the MDT. 
In England around £300 million of NHS prescribed medicines are wasted each year; the 
causes of waste vary from inefficient prescribing and stock piling, to patient recovery and 
non-adherence.9 Medicines management teams have the potential to reduce waste medication 
by optimising medicines and increasing patients’ adherence to their medication. Medicines 
optimisation looks at how patients use their medicines over time. Stopping or stepping down 
the doses of medicines, starting or increasing the doses of others, or altering the frequency to 
simplify the patient’s medication regime.10 
Furthermore, it is suggested that when patients move between care providers the risk of 
miscommunication and unintended changes to medication are a significant problem, with up 
to 70% of patients experiencing an error or an unintentional change to their medicines.11 
Incidents such as these can also lead to unnecessary hospital admissions, with four to five 
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percent of hospital admissions being due to preventable problems with medicines.12 As 
members of the VW MDT, a medicines management team is well placed to facilitate 
communication about patients’ medicines between health and social care practitioners within 
the same or different sectors. 
There is a dearth of research on the role and impact that pharmacists, and indeed medicines 
management teams (to include pharmacy technicians) have as members of a VW MDT. One 
international study compared six VW models across the UK, the United States of America 
(USA) and Canada, and reported  pharmacists as being part-time members of four of these 
(UK = three, Canada = one).13 A more recent case study report described the care practice 
within three of the four UK based VWs, and described the presence of a pharmacist within 
two out of the three MDTs associated with these.14 Neither study discussed the actual role 
played by the pharmacist within the MDT, or the impact of this contribution.13, 14  
Within the USA a model similar to VWs exists called the Patient-Centred Medical Home 
(PCMH). This is a collaborative model of team-based care with the core principles of 
providing patient-centred, co-ordinated care with enhanced access for patients; and a 
systems-based approach to quality and safety. A PCMH team may or may not be virtual, and 
services may be delivered from various locations, and not necessarily within a patient’s 
home.15 Pharmacists are rarely mentioned in medical home discussions, but the 
complementary skills and knowledge of pharmacists and prescribers have been accredited to 
delivering improved patient care and medicines management for patients; in particular those 
with long-term conditions.16  
Novel to this particular NW of England VW is input from a dedicated medicines management 
team, comprising four pharmacists and four pharmacy technicians (1.6 whole time 
equivalents). The team delivers medicines management support to selected VW patients.  
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Since the inception of the VW in 2013, the medicines management team have delivered 
support (medicines optimisation; strategies and aids to help increase medicines adherence and 
interventions to reduce waste medication) to over 932 patients; hence a need was identified to 
explore the impact of this service.  The aim of the study therefore was to evaluate the 
inclusion of a medicines management service provided by a dedicated medicines 
management team within a VW.  
Method 
Study design 
To address the aim of the study a qualitative approach was employed using focus groups to 
promote group discussion and to explore the views and experiences of the medicines 
management and multi-disciplinary teams respectively.17 A purposive sampling approach was 
employed to recruit participants. Potential participants for both focus groups were identified 
and approached to engage in the study via the head of the VW medicines management team.  
Focus group interview schedules were developed, discussed and further refined by the project 
team after reviewing the literature and receiving feedback from the head of the head of the 
VW medicines management team and the deputy chief nurse of the CCG (Tables 1 and 2). 
Insert Table 1 here (see end of document) 
Insert Table 2 here (see end of document) 
Procedure 
Letters of invitation and participant information sheets were sent to potential participants of 
both focus groups by the VW service leads on behalf of the research team. Written consent 
was obtained from all participants prior to data collection.  The study was deemed to be a 
service evaluation by the Research and Development Committees of the relevant NHS Trusts, 
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and ethical approval was granted by the University Faculty Ethics Committee. The focus 
groups were held in May - June 2015. Both lasted less than one hour, and were audio-
recorded and moderated by one researcher (LC) with another (AK) present in a note-taking 
capacity. 
Data analysis 
The audio-recordings were anonymised and transcribed in full. Following this, each transcript 
was independently read and re-read by two members of the research team (LC and AK) until 
a thorough understanding of the content was achieved. Using thematic analysis, one of the 
most common form of analysis in qualitative research, commonalities and differences 
amongst the accounts were identified as patterns or themes within the data.18 Categorisation 
of the data followed, whereby these early themes were formed into descriptive codes, and the 
data subsequently reduced to provide support for the initial conclusions, before meeting with 
a third researcher (BJ) to discuss and confirm the final coding frame19, 20. 
Results 
Study participants 
A total of eight medicines management team members (pharmacists and technicians) were 
invited, with five agreeing to participate. Within the wider multi-disciplinary team, 27 
members were invited and nine agreed to participate. These comprised: a health trainer, 
physiotherapist, social worker, occupational therapist, community matrons and district 
nurses. 
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Themes 
Thematic analysis of both focus groups identified three main themes: Impact on Patients and 
Carers, Team Working, and Issues and Challenges; each containing sub-themes.  The results 
of the analysis will be discussed systematically using the thematic headings (Fig. 1). The 
medicines management team focus group will be denoted as FG1, the multi-disciplinary team 
focus group as FG2 and the participants within each by the use of P with their corresponding 
identification number e.g. P1, P2. 
Insert Fig. 1. Here (see end of document). 
Impact on Patients and Carers 
The medicines management team considered that they frequently acted as a link between the 
patients’ different care providers, supplying and clarifying information regarding the patients’ 
medication. Such information, often acquired upon visiting the patient at home, enabled the 
team to address confusion between different care providers and improve communication: 
“. . . they [the patient] had been supplied with it [warfarin] by the hospital, but at that point 
the GP wasn't aware that the patient was actually taking warfarin, because the GP had 
actually stopped it . He had stopped it because I think she [the patient] was just non-
compliant with her meds. But the hospital, not aware of the compliance issue, had re-initiated 
it.“ (FG1P1) 
An intervention frequently reported by the medicines management team was the provision of 
medication management aids (from now on referred to as ‘aids’) to assist patients to use their 
medicines correctly, so encouraging adherence, and believed by the team on some occasions 
to prevent hospital admissions. It was suggested that at times, the provision of aids to assist in 
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the management of a patient’s medication was actually more helpful to the patient’s carer 
than to the patient, though it was also thought to protect patients from harm: 
“. . . we’ve got a lady who has had to have a little safe to put the blister packs in, you 
know, that just the carers have got the pin to open it and put in medication and that . . 
. [she] has dementia problems, she would overdose . . . so that was the safety aspect 
of it.“ (FG2P6) 
The medicines management team also cited an occasion where the provision of an aid to a 
patient had not had such a positive outcome: 
“. . . we gave him [the patient] an alarm clock to help him remember to take his 
medication. The patient had schizophrenia. Despite me changing the alarm clock to 
beep, he'd switched it to voice; and so when the voice went off to take his medication, 
he believed God was speaking to him and he stopped taking all medication!“ (FG1P3) 
Patients’ lack of understanding about their medication was highlighted as sometimes leading 
to adverse events. Both teams believed that patients benefited from being educated about 
their medication. The medicines management team in particular, saw this as part of their role, 
and suggested that this helped to increase patients’ adherence to their medication: 
“It's about people's understandings, and we're trying to encourage them [patients] to 
ask questions and to increase their knowledge around their medication . . . they say 
they don't really know why they're taking their medication, and so we will often 
provide them with an information sheet explaining what the medication is, how often 
they take it, and what it's used for, and try and stress the importance of taking your 
regular medication and the reasons behind that, so they're given a rationale for, you 
know, their compliance really.” (FG1P4) 
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Another of the sub-themes that resonated with both teams was medicines optimisation. When 
carried out by the medicines management team this was suggested to not only be of benefit to 
patients, but also carers: 
“. . . it’s just a fantastic review of the patient isn’t it, that they get and they [medicines 
management team] highlight issues. . .  obviously as you get older it’s all 
polypharmacy. Sometimes they [medicines management team] can reduce things, or 
you know, different medication that does the same job with one tablet, or they can put 
all the tablets together once a day to cut down all the issues with taking them. It’s 
fantastic yeah, it’s great.” (FG2P3) 
The multi-disciplinary team additionally identified that for certain patients, it was necessary 
to take a step back and to consider stopping some medication, and that the medicines 
management team would support them with this: 
“. . . I think it’s having the courage to say, ‘Look enough is enough’. They’ve got all 
these tablets that they’re [the patients] not taking and we need to stop it. We need to 
go back to the GP and say, ‘look you know, be realistic, they’re not benefiting from 
this’ . . .  they [medicines management team] tend to support us [multi-disciplinary 
team] more going back to the GP and saying ‘look I think we need to reduce some of 
these medications’.” (FG2P6) 
The value of visiting patients at home was raised several times by the medicines management 
team, who felt that patients were often more confident when being visited in their own 
homes; talking more openly when discussing their medicines than would have been the case 
in an alternative environment. It was also highlighted that social, environmental and family 
concerns were often identified. The medicines management team recounted how they 
frequently signposted patients (and carers) to the wider multi-disciplinary team for support of 
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non-medicines issues. Joint visits by members of both teams were stated as being especially 
productive and providing holistic care, as several aspects of a patient’s needs could be 
addressed by one visit. Both teams reported frequently finding large quantities of unwanted 
and unused medication.  They explained how they used this as an indicator of non-adherence, 
often seeing it linked to adverse events experienced by the patient: 
“. . . every time she [the patient] went to the GP, her blood pressure wasn't controlled 
. . . so the GP kept increasing her blood pressure medication, and when we went 
round we removed four bin bags of blister packs because the lady had literally not 
taken any medication.” (FG1P3) 
Team Working  
Both focus groups referred to the advantages of working together within the VW, how this 
affected their specific roles, and the benefits this brought to the patients. Sub-themes 
included: Joined-up thinking and Inter-Professional Education. 
Participants in both groups discussed how the information provided by the individual 
members of the VW often ‘joined up’ and ‘made sense’ once the information was shared 
between the whole VW team.  One participant noted: 
“I think the multi-disciplinary teams are vital because you have all this information, 
and yet you can go and sit in a multi-disciplinary team meeting, and one of those 
other disciplines will throw something into the mix, and that fits the puzzle; so you 
have a much clearer picture.” (FG1P2) 
Similarly, another participant remarked: 
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“And they [medicines management team] really help with obviously like rehab for 
ourselves, you know, therapy input, because patients aren’t taking the medication 
correctly, or you know, not taking them at all. You know sometimes it affects their 
motivation and things, depending on what they’re on, so obviously it helps with their 
participation in rehab . . . and also the falls side of things again, you know if they’re 
not taking medication correctly, that contributes to falls, so it’s really helpful.” 
(FG2P3) 
The multi-disciplinary team reported their appreciation of the education given by the 
medicines management team, acknowledging their role as ‘experts’ in medicines. Education 
was imparted in both an organised manner through training sessions, and ad hoc through day 
to day working, side-by-side on the VW: 
“. . . and yeah it has been beneficial . . . some of the meds management team have 
done like a training session and brought some of the aids, you know, some of the 
assistive aids you can get, and brought them for us to have a look at. So that’s been 
really useful.” (FG2P3) 
Issues and challenges 
A final theme to emerge (along with its attendant sub-themes), was the Issues and Challenges 
that the medicines management team had experienced whilst delivering their service to date. 
The medicines management team described how occasionally patients’ expectations were 
raised by the VW before they had assessed a patient’s needs: 
“The district nurse had said, ‘Oh, I think you need a blister pack’, and then when we 
went to see the gentleman, he didn't actually need a blister pack. So then, we had to 
explain why he didn't. . . .  the GP said ‘No, I don't want him to have a blister pack. 
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He doesn't need blister packs. He’s not appropriate for them’ . . .  the patient was 
fine, and we explained… and almost, like, contradict another healthcare professional, 
which is quite difficult really.” (FG1P4) 
The medicines management team also described the challenge of accessing a patient’s health 
records held by the patient’s GP. The team explained that they had to physically attend the 
GP surgery to read the notes as they were unable to access them remotely on-line. 
“We [medicines management team] have had so many IT issues, where, because 
we're not employed by (NHS Trust) we've not been able to remotely access records 
(via electronic patient record software system) for the virtual ward patients. So, we 
have to run round GP surgeries trying to get brief summaries.” (FG1P5) 
The distressing nature of some of the situations experienced during domiciliary visits was 
raised as a concern by medicines management team participants. However, they voiced the 
opinion that they were a ‘close-knit’ team, and were able to support each other when such 
instances arose:  
“Some of the situations that we can encounter with no warning can be quite 
distressing; a patient's living conditions . . . can be quite difficult . . . to actually sit in 
someone's home in that environment, or the patients’ stories can be quite tragic 
and…hard really, to deal with . . .  so we sort of support each other really.” (FG1P5) 
“I think for us as a team . . .  we're very fortunate that we are quite a close-knit little 
group… and I wouldn't hesitate for a minute to say to somebody  . . .  ‘Do you fancy a 
coffee?’ . . . We've come out of homes and thought ‘Oh my goodness me’ . . .  but I 
think we're lucky that we've got one another . . .  and we are a close-knit little group.” 
(FG1P2) 
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The majority of the VW patients were elderly and often had complex medical conditions. The 
medicines management team participants emphasised how this and the increasing number of 
patients with memory and mental health issues, impacted upon the time and skills needed to 
deliver their service:  
“The patients are a lot more complex. They may be not the correct patients to be on 
the virtual ward from the original conception, but that's the reality that some very 
complex patients with a lot of issues and problems are the patients that we visit.” 
(FG1P5) 
Furthermore, the medicines management team identified that the elderly patients were also 
slower in their ability to participate physically and mentally in a review of their medication, 
again impacting on the time taken to complete a medication review: 
  “. . . we're dealing with very elderly people who are a lot slower, even slower to 
answer the door, slower to walk back to the room, may go and visit the toilet in the 
middle of the visit…but equally, it's to gain their trust . . . you have to listen to a lot of 
the stuff that's not related to your visit to reach the point where you can then start 
asking them questions.” (FG1P5) 
Discussion 
Evidence has indicated that up to 70% of patients experience an error or an unintentional 
change to their medication when their care is transferred.21 In the USA, 60% of medication 
errors were found to occur at the time of transition between care providers.22 High rates of 
medication discrepancies have also been found during patient transition between hospital and 
community environments within Europe.23 Incidents such as these can lead to unnecessary 
hospital admissions and re-admissions, with four to five percent of hospital admissions being 
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due to preventable problems with medicines.12 National guidance advises that it is the 
responsibility of all professionals involved in the care of a patient to ensure the safe transfer 
of information about their medicines.24-26 Several members of the medicines management 
team explained how they were frequently required to transfer information between, and to, 
care providers regarding patients’ medication; so ‘joining them up’.  
This role of provider of information regarding a patient’s medication was to emerge again, in 
another sub-theme entitled Patient Education, where information was given to the patients 
themselves in order to attempt to increase their adherence to their medicines. A role mirrored 
by PCMH pharmacists.27 As members of the wider multi-disciplinary VW team, it could be 
suggested that the medicines management team is well placed to facilitate communication 
about patients’ medicines between health and social care practitioners within the same or 
different sectors. 
Our findings also reported the differing interventions made by the medicines management 
team to support patients’ adherence to their medicines. Alongside the practical factors that 
increased the ability of the patients to take and use their medicines correctly, interventions 
took account of patients’ beliefs and preferences in order to influence and motivate 
continuation of treatment.  This is especially noteworthy when considering that unintentional 
adherence is frequently caused by the failure of care providers to adequately identify and 
provide the support that patients need to commence, continue or use their medication.25 It is 
recommended that support should start by exploring patients' perceptions of their medicines 
and the reasons why they may not want or are unable to take or use them.25 
The medicines management team reflected on the value of domiciliary visiting, and the 
insight that could be provided into a patient’s social, environmental and domestic status. The 
value of carrying out medication reviews in patients’ homes has been acknowledged 
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previously by other medicines management teams, where pharmacists have been able use 
their intuition, knowledge and people skills to make medicines fit better into patients’ lives; 
so further supporting medicines adherence. 28 
Medicines management teams have the potential to reduce waste medication by optimising 
medicines and increasing virtual ward patients’ adherence to their medication.10  For 
members of both the multi-disciplinary and medicines management teams it was considered 
an almost routine and essential intervention carried out by the medicines management team 
for a majority of the VW patients. In delivering this valued intervention, the medicines 
management team are working in line with the principles for medicines optimisation as 
suggested by the Royal Pharmaceutical Society.10 
Both the multi-disciplinary and the medicines management teams explained how they 
supported the other within the VW. Members of the multi-disciplinary team also described 
how they valued the education around medicines given to them by the medicines 
management team.  In particular, both teams expressed their opinions of the value of them all 
meeting together on a regular basis to discuss individual patients. This mirrored research by 
Lewis et al., who explored the integration of VWs within three sites in England.14 Lewis et 
al. concluded that where there were regular multi-disciplinary team meetings within a VW 
and a set of shared values was fostered amongst the wider multi-disciplinary team, this 
provided a focus for integration. Virtual ward meetings also providing a forum in which the 
care of the VW patients could be discussed reviewed and a multi-disciplinary team care plan 
put into place. Furthermore, regular meetings of the VW team were seen to sustain the multi-
disciplinary model of care, preventing it from reverting back to the traditional model of one 
to one case management.(10) Lewis et al. also identified a number of the same issues 
acknowledged as areas of concern for this medicines management team, such as access to 
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patient records, also highlighted by PCMH pharmacists; and the length and nature of 
medication reviews.14, 29, 30  
Overall, this medicines management team within the VW model of case management, 
although recognised as one service with a modest number of patients, appears to be helping to 
increase the support given to patients, carers and health and social care providers. In the 
challenging environment of complex medical conditions, polypharmacy and an ever growing 
elderly population with mental health and memory issues, it is suggested that the medicines 
management team are helping to increase the quality of patient care and patient outcomes.  
Study limitations 
This study was conducted at one site. Due to the low numbers and disparity of models of 
VWs across the country, in particular the composition of the multi-disciplinary teams within 
these, it is unclear how transferable these findings will be.  However, this model has already 
been used to deliver a VW medicines management service in one locality, suggesting 
potential for transferability across a wider area.  
However, it is recognised that the study could be strengthened by the inclusion of patient and 
carer voices on the survey. An economic evaluation would also offer further insight into the 
inclusion of a medicines management service provided by a dedicated medicines 
management team within a VW. 
Conclusion 
In summary, this study has elicited the perceptions of the contribution of the medicines 
management team to the VW of both the medicines management team and the wider multi-
disciplinary team. Overall the results indicate a positive experience for both teams, and that 
the medicines management team is working in line with national recommendations and 
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guidelines around several aspects of medicines management, ultimately increasing the quality 
of patient care overall.9,10, 21, 24, 25    
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Table 1  
Focus group interview schedule of the virtual ward medicines management team
 
What do you think in general about the virtual ward medicines management service? 
How do you feel about the change in your role from that working within the virtual ward 
team and that of your normal medicines management function? What are the positives and 
negatives of these? 
Thinking back to the service(s) you have recently delivered the, what impact/ difference, if 
any, do you think that this has made to the patient(s)? Can you give a clinical example of an 
intervention carried out by the medicines management team which has prevented or may 
have prevented an admission to hospital? 
What do you feel about the supervisory role? How is this working? 
Thinking back to the service(s) you have recently delivered, what impact/ difference, if any, 
do you feel that this has made to the family carer(s)? 
Thinking back to the service(s) you have recently delivered by the medicines management 
team. What went well? What went less well? 
Regarding the virtual ward medicines management service, what would you change if you 
could? (Prompts: Referral process? How do feel about how decisions are made? How you 
interact with one another? Interaction with other members of the VM? Communication? 
Outcomes? ) 
Are there any other services that you think that the medicines management team 
could/should offer to the virtual ward patients? 
Do you feel that you have any developmental needs? 
Is there anything I didn’t ask that you’d like to discuss about the virtual ward medicines 
management service? 
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Table 2 
Focus group interview schedule of the virtual ward multi-disciplinary team 
What do you think in general about the virtual ward medicines management service? 
How do you think that the relationships are between yourselves and the medicines 
management team? 
How have these developed? 
Do you think that there are any benefits to these new relationships? 
Have your expectations changed as a result of working alongside the medicines management 
team? 
Are you aware of all of the services that the medicines management team can offer to 
patients? 
What specific services provided by the medicines management team have you seen delivered 
in practice? 
Thinking back to the service(s) you have recently seen delivered by the medicines 
management team, what impact/ difference, if any, do you think that this has made to the 
patient(s)? 
Thinking back to the service(s) you have recently seen delivered by the medicines 
management team, what impact/ difference, if any, do you feel that this has made to the 
family carer(s)? 
Thinking back to the service(s) you have recently seen delivered by the medicines 
management team. What went well? What went less well? 
Regarding the medicines management service, what would you change if you could? 
(Prompts: Referral process? How do feel about how decisions are made? Interaction with the 
medicines management team? Communication? Outcomes? ) 
Are there any other services that you think that the medicines management team could/should 
offer to the virtual ward patients? 
Thinking back to the service(s) you have recently seen delivered by the medicines 
management team, has the medicines management service impacted on your role? If so, how? 
Is there anything I didn’t ask that you’d like to discuss about the virtual ward medicines 
management service? 
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                         Fig. 1.  Key themes to emerge from the data  
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